MRK Total Utang marang Modal Merck Sharp & Dohme

The financial stability of Merck & Co., Inc. (MRK) is based on the success of Keytruda and vaccine development. However, patent expirations and pricing pressure create serious risks for profits. On GURU.Markets, the current debt-to-equity ratio demonstrates leverage dynamics, where the actual value equals 1.35. The company's operating model relies on large-scale outsourcing of primary molecule synthesis.

This indicator determines the degree of financial leverage by comparing total liabilities to the business's equity. The current total debt-to-equity ratio, equal to 1.35, reflects the balance between debt and equity capital. An increase in this metric signals a higher debt load and rising borrowing costs. Stability of this indicator is critically important for Merck & Co., Inc. (MRK), as it enables the company to effectively finance expansion into emerging markets and scale sales of high-demand oncology drugs.